Home > Boards > US Listed > Medical - Equipment > Obalon Therapeutics, Inc. (OBLN)

Probably will drop share price again next week

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
x1power Member Profile
 
Followed By 31
Posts 1,393
Boards Moderated 0
Alias Born 10/01/12
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 10/3/2019 9:16:14 AM
Obalon Announces Repayment of All Long-Term Debt and Regaining of Compliance with NASDAQ Listing Requirement GlobeNewswire Inc. - 10/3/2019 9:00:00 AM
Obalon (OBLN) Alert: Johnson Fistel Announces Shareholder Class Action Against Obalon Therapeutics Survives Motion to Dismiss... PR Newswire (US) - 9/28/2019 12:42:00 PM
Obalon Engages Helmuth T. Billy, MD as Medical Director for its First Company-Owned Weight Loss Treatment Center GlobeNewswire Inc. - 9/3/2019 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/8/2019 4:28:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/8/2019 4:24:32 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 8/8/2019 4:17:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/8/2019 2:29:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/8/2019 2:28:40 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/8/2019 2:28:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/8/2019 2:28:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/8/2019 2:27:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/8/2019 2:27:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/8/2019 2:27:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/8/2019 2:26:21 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 8/8/2019 12:53:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/8/2019 11:11:20 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2019 4:05:07 PM
Obalon Therapeutics Inc. Announces Closing of $16.6 Million Public Offering GlobeNewswire Inc. - 8/6/2019 4:01:00 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/6/2019 2:57:32 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/6/2019 1:29:01 PM
Obalon Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference GlobeNewswire Inc. - 8/5/2019 9:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 8/5/2019 6:17:54 AM
Obalon Therapeutics Inc. Announces Pricing of $15,000,000 Public Offering GlobeNewswire Inc. - 8/2/2019 8:48:41 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 8/2/2019 6:00:55 AM
x1power   Saturday, 12/22/18 07:37:29 PM
Re: trader85 post# 61
Post # of 493 
Probably will drop share price again next week . . . lots of Friday trade
volume to short towards normal volume daily range?

To me . . . Friday late day stock price rise indicates someone other than small time day traders and shorts is behind activity.

Close to $2 is still fairly decent entrance buy point?
Lets see if company wants its stock price far below $2 . . . if so it thus might mean new stock offering is transpiring. OBLN going to need millions
in sales and training and production costs in 2019 to expand (will they just 'dip' into their present limited cash to achieve that)?

Company salaries and normal business expenses for say 60 employees and
owners will take up quite a lot of present cash company has.
A couple of $100K spend wouldn't do it.

For me (if chose to buy) it would be LT hold position.
If sales expand and revs delta . . . Hedge Funds will buy in.
FDA must have felt company product is very safe.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist